Skip to main content
Top
Published in: Surgical Endoscopy 9/2022

18-01-2022 | Gastroesophageal Reflux Disease | 2021 SAGES Oral

S148: Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation versus Nissen fundoplication: a 5-year follow-up study

Authors: Sean M. O’Neill, Anahita D. Jalilvand, Jennifer S. Colvin, Kelly R. Haisley, Kyle A. Perry

Published in: Surgical Endoscopy | Issue 9/2022

Login to get access

Abstract

Background

Laparoscopic magnetic sphincter augmentation (MSA) has emerged as an alternative to laparoscopic Nissen fundoplication (LNF) for the management of symptomatic gastroesophageal reflux disease (GERD). While short-term outcomes of MSA compare favorably to those of LNF, direct comparisons of long-term outcomes are lacking. We hypothesized that the long-term patient-reported outcomes of MSA would be similar to those achieved with LNF.

Methods

We tested this hypothesis in a retrospective cohort undergoing primary LNF or MSA between March 2013 and July 2015. The primary outcome was GERD-Health Related Quality of Life (GERD-HRQL) score at long-term follow-up relative to baseline. Secondary outcomes included dysphagia and bloating scores, proton-pump inhibitor (PPI) cessation, reoperations, and overall satisfaction with surgery.

Results

70 patients (25 MSA, 45 LNF) met criteria for study inclusion. MSA patients had lower baseline BMI (median: 27.1 [IQR: 22.7–29.9] versus 30.4 [26.4–32.8], p = 0.02), lower total GERD-HRQL (26 [19–32] versus 34 [25–40], p = 0.02), and dysphagia (2 [0–3] versus 3 [1–4], p = 0.02) scores. Median follow-up interval exceeded 5 years (MSA: 68 [65–74]; LNF: 65 months [62–69]). Total GERD-HRQL improved from 26 to 9 after MSA (p < 0.001) and from 34 to 7.5 after LNF (p < 0.01); these scores did not differ between groups (p = 0.68). Dysphagia (MSA: 1 [0–2]; LNF: 0 [0–2], p = 0.96) and bloating (MSA: 1.5 [0.5–3.0]; LNF: 3.0 [1.0–4.0], p = 0.08) scores did not show any statistically significant differences. Device removal was performed in 4 (16%) MSA patients and reoperation in 3 (7%) LNF patients. Eighty-nine percent of LNF patients reported satisfaction with the procedure, compared to 70% of MSA patients (p = 0.09).

Conclusions

MSA appears to offer similar long-term improvement in disease-specific quality of life as LNF. For MSA, there was a trend toward reduced long-term bloating compared to LNF, but need for reoperation and device removal may be associated with patient dissatisfaction.
Literature
1.
go back to reference Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC (2018) Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 67(3):430–440CrossRef Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC (2018) Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 67(3):430–440CrossRef
2.
go back to reference Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW (2012) Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 10(6):612–619CrossRef Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW (2012) Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 10(6):612–619CrossRef
3.
go back to reference Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, Lundell L, LOTUS Trial Collaborators (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 305(19):1969–1977CrossRef Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, Lundell L, LOTUS Trial Collaborators (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 305(19):1969–1977CrossRef
4.
go back to reference Hatlebakk JG, Zerbib F, Bruley des Varannes S, Attwood SE, Ell C, Fiocca R, Galmiche JP, Eklund S, Långström G, Lind T, Lundell LR, LOTUS Study Group (2016) Gastroesophageal acid reflux control 5 years after antireflux surgery, compared with long-term esomeprazole therapy. Clin Gastroenterol Hepatol 14(5):678–85.e3CrossRef Hatlebakk JG, Zerbib F, Bruley des Varannes S, Attwood SE, Ell C, Fiocca R, Galmiche JP, Eklund S, Långström G, Lind T, Lundell LR, LOTUS Study Group (2016) Gastroesophageal acid reflux control 5 years after antireflux surgery, compared with long-term esomeprazole therapy. Clin Gastroenterol Hepatol 14(5):678–85.e3CrossRef
5.
go back to reference Spechler SJ, Hunter JG, Jones KM, Lee R, Smith BR, Mashimo H, Sanchez VM, Dunbar KB, Pham TH, Murthy UK, Kim T, Jackson CS, Wallen JM, von Rosenvinge EC, Pearl JP, Laine L, Kim AW, Kaz AM, Tatum RP, Gellad ZF et al (2019) Randomized trial of medical versus surgical treatment for refractory heartburn. N Engl J Med 381(16):1513–1523CrossRef Spechler SJ, Hunter JG, Jones KM, Lee R, Smith BR, Mashimo H, Sanchez VM, Dunbar KB, Pham TH, Murthy UK, Kim T, Jackson CS, Wallen JM, von Rosenvinge EC, Pearl JP, Laine L, Kim AW, Kaz AM, Tatum RP, Gellad ZF et al (2019) Randomized trial of medical versus surgical treatment for refractory heartburn. N Engl J Med 381(16):1513–1523CrossRef
6.
go back to reference Liu JY, Finlayson SR, Laycock WS, Rothstein RI, Trus TL, Pohl H, Birkmeyer JD (2003) Determining an appropriate threshold for referral to surgery for gastroesophageal reflux disease. Surgery 133(1):5–12CrossRef Liu JY, Finlayson SR, Laycock WS, Rothstein RI, Trus TL, Pohl H, Birkmeyer JD (2003) Determining an appropriate threshold for referral to surgery for gastroesophageal reflux disease. Surgery 133(1):5–12CrossRef
7.
go back to reference Finlayson SR, Birkmeyer JD, Laycock WS (2003) Trends in surgery for gastroesophageal reflux disease: the effect of laparoscopic surgery on utilization. Surgery 133(2):147–153CrossRef Finlayson SR, Birkmeyer JD, Laycock WS (2003) Trends in surgery for gastroesophageal reflux disease: the effect of laparoscopic surgery on utilization. Surgery 133(2):147–153CrossRef
8.
go back to reference Bonavina L, DeMeester T, Fockens P, Dunn D, Saino G, Bona D, Lipham J, Bemelman W, Ganz RA (2010) Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg 252(5):857–862CrossRef Bonavina L, DeMeester T, Fockens P, Dunn D, Saino G, Bona D, Lipham J, Bemelman W, Ganz RA (2010) Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg 252(5):857–862CrossRef
9.
go back to reference Asti E, Aiolfi A, Lazzari V, Sironi A, Porta M, Bonavina L (2018) Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies. Updates Surg 70(3):323–330CrossRef Asti E, Aiolfi A, Lazzari V, Sironi A, Porta M, Bonavina L (2018) Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies. Updates Surg 70(3):323–330CrossRef
10.
go back to reference Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, DeVault KR, Horgan S, Jacobsen G, Luketich JD, Smith CC, Schlack-Haerer SC, Kothari SN, Dunst CM, Watson TJ, Peters J, Oelschlager BK, Perry KA, Melvin S, Bemelman WA, Smout AJ et al (2016) Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol 14(5):671–677CrossRef Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, DeVault KR, Horgan S, Jacobsen G, Luketich JD, Smith CC, Schlack-Haerer SC, Kothari SN, Dunst CM, Watson TJ, Peters J, Oelschlager BK, Perry KA, Melvin S, Bemelman WA, Smout AJ et al (2016) Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol 14(5):671–677CrossRef
11.
go back to reference Ferrari D, Asti E, Lazzari V, Siboni S, Bernardi D, Bonavina L (2020) Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease. Sci Rep 10(1):13753CrossRef Ferrari D, Asti E, Lazzari V, Siboni S, Bernardi D, Bonavina L (2020) Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease. Sci Rep 10(1):13753CrossRef
12.
go back to reference Bonavina L, Horbach T, Schoppmann SF, DeMarchi J (2021) Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication. Surg Endosc 35(7):3449–3458CrossRef Bonavina L, Horbach T, Schoppmann SF, DeMarchi J (2021) Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication. Surg Endosc 35(7):3449–3458CrossRef
13.
go back to reference Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217–224PubMed Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217–224PubMed
14.
go back to reference Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W, Goldsmith C (2006) A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: one-year follow-up. Surg Innov 13:238–249CrossRef Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W, Goldsmith C (2006) A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: one-year follow-up. Surg Innov 13:238–249CrossRef
15.
go back to reference Ayazi S, Zheng P, Zaidi AH, Chovanec K, Salvitti M, Newhams K, Hoppo T, Jobe BA (2020) Clinical outcomes and predictors of favorable result after laparoscopic magnetic sphincter augmentation: single-institution experience with more than 500 patients. J Am Coll Surg 230(5):733–743CrossRef Ayazi S, Zheng P, Zaidi AH, Chovanec K, Salvitti M, Newhams K, Hoppo T, Jobe BA (2020) Clinical outcomes and predictors of favorable result after laparoscopic magnetic sphincter augmentation: single-institution experience with more than 500 patients. J Am Coll Surg 230(5):733–743CrossRef
16.
go back to reference Asti E, Bonitta G, Lovece A, Lazzari V, Bonavina L (2016) Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation: Observational cohort study with propensity score analysis. Medicine 95(30):e4366CrossRef Asti E, Bonitta G, Lovece A, Lazzari V, Bonavina L (2016) Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation: Observational cohort study with propensity score analysis. Medicine 95(30):e4366CrossRef
17.
go back to reference Reynolds JL, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham JC (2015) Laparoscopic magnetic sphincter augmentation vs laparoscopic Nissen fundoplication: a matched-pair analysis of 100 patients. J Am Coll Surg 221(1):123–128CrossRef Reynolds JL, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham JC (2015) Laparoscopic magnetic sphincter augmentation vs laparoscopic Nissen fundoplication: a matched-pair analysis of 100 patients. J Am Coll Surg 221(1):123–128CrossRef
18.
go back to reference Warren HF, Reynolds JL, Lipham JC, Zehetner J, Bildzukewicz NA, Taiganides PA, Mickley J, Aye RW, Farivar AS, Louie BE (2016) Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc 30(8):3289–3296CrossRef Warren HF, Reynolds JL, Lipham JC, Zehetner J, Bildzukewicz NA, Taiganides PA, Mickley J, Aye RW, Farivar AS, Louie BE (2016) Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc 30(8):3289–3296CrossRef
19.
go back to reference Riegler M, Schoppman SF, Bonavina L, Ashton D, Horbach T, Kemen M (2015) Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc 29(5):1123–1129CrossRef Riegler M, Schoppman SF, Bonavina L, Ashton D, Horbach T, Kemen M (2015) Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc 29(5):1123–1129CrossRef
Metadata
Title
S148: Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation versus Nissen fundoplication: a 5-year follow-up study
Authors
Sean M. O’Neill
Anahita D. Jalilvand
Jennifer S. Colvin
Kelly R. Haisley
Kyle A. Perry
Publication date
18-01-2022
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 9/2022
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-022-09015-1

Other articles of this Issue 9/2022

Surgical Endoscopy 9/2022 Go to the issue